2025年1月7日 · Ucol Tablet 2 mg is indicated for the treatment of an overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Extended-release capsule: The recommended dose is Ucol Tablet 2 mg 4 mg once daily. The dose may be lowered to 2 mg once daily based on individual response and tolerability.

Ucol is indicated for the treatment of an overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

2025年1月7日 · Tolterodine is a competitive, specific muscarinic receptor antagonist which exhibits a selectivity for the urinary bladder over salivary glands, which have been demonstrated in non clinical pharmacological in vivo studies. Tolterodine has …

Ucol 2 mg is indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence. Theropeutic Class BPH/ Urinary retention/ Urinary incontinence

Ucol 2mg Tablet is used in the treatment of overactive bladder. It relieves urinary symptoms like frequent urination, urgent need to urinate, and inability to control urination. Ucol 2mg Tablet is advised to take it in a dose and duration as per prescription.

Ucol® is indicated for the treatment of overactive bladder with symptoms of urinary urgency, frequency, and/or urge incontinence. The recommended dose for Ucol® is 2 mg b.i.d. In case of troublesome side-effects the dose may be reduced from 2 mg to 1 mg b.i.d..

Ucol Tablet is used for: Overactive bladder. Oral Overactive Bladder, Urge Incontinence Immediate release: 2 mg PO q12hr. Reduce to 1 mg bid if needed to reduce side effects.

2025年1月7日 · Ucol Tablet 2 mg is indicated for the treatment of an overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Ucol Tablet 2 mg এর দাম কত? Ucol Tablet 2 mg এর দাম Unit Price: ৳ 4.00 (6 x 10: ৳ 240.00) Strip Price: ৳ 40.00. Ucol Tablet 2 mg খাওয়ার নিয়ম / ব্যবহারের নিয়ম.

2025年1月7日 · Ucol is a competitive, specific muscarinic receptor antagonist which exhibits a selectivity for the urinary bladder over salivary glands, which have been demonstrated in non clinical pharmacological in vivo studies.